NextCell Pharma AB (NXTCL) — Working Capital to Net Assets Ratio
NextCell Pharma AB (NXTCL) has a Working Capital to Net Assets ratio of 73.8% as of August 2025. Working capital of Skr48.97 Million (current assets of Skr54.40 Million minus current liabilities of Skr5.43 Million) is measured against net assets of Skr66.39 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See how leveraged is NextCell Pharma AB's balance sheet to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
NextCell Pharma AB Working Capital to Net Assets (2015–2025)
This chart shows how NextCell Pharma AB's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2015 to 2025. As of August 2025, the ratio stands at 73.8%, reflecting working capital of Skr48.97 Million against net assets of Skr66.39 Million SEK. Check NextCell Pharma AB (NXTCL) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for NextCell Pharma AB (2015–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for NextCell Pharma AB from 2015 to 2025, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market cap of NextCell Pharma AB.
| Year | WC/NA Ratio | Working Capital (SEK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 73.8% | Skr48.97 Million | Skr66.39 Million | Skr54.40 Million | Skr5.43 Million | ▼ -1.3 pp |
| 2024 | 75.1% | Skr50.75 Million | Skr67.60 Million | Skr60.62 Million | Skr9.87 Million | ▼ -0.4 pp |
| 2023 | 75.5% | Skr57.19 Million | Skr75.73 Million | Skr67.27 Million | Skr10.08 Million | ▼ -10.9 pp |
| 2022 | 86.4% | Skr99.82 Million | Skr115.54 Million | Skr106.75 Million | Skr6.93 Million | ▼ -8.6 pp |
| 2021 | 95.0% | Skr142.52 Million | Skr150.09 Million | Skr146.48 Million | Skr3.96 Million | ▲ +4.0 pp |
| 2020 | 91.0% | Skr23.86 Million | Skr26.22 Million | Skr26.03 Million | Skr2.17 Million | ▲ +2.2 pp |
| 2019 | 88.8% | Skr20.38 Million | Skr22.96 Million | Skr23.20 Million | Skr2.82 Million | ▲ +42.4 pp |
| 2018 | 46.3% | Skr2.33 Million | Skr5.04 Million | Skr5.04 Million | Skr2.71 Million | ▼ -37.6 pp |
| 2017 | 83.9% | Skr16.00 Million | Skr19.07 Million | Skr17.86 Million | Skr1.86 Million | ▲ +18.2 pp |
| 2016 | 65.7% | Skr4.44 Million | Skr6.76 Million | Skr6.44 Million | Skr2.00 Million | ▼ -9.1 pp |
| 2015 | 74.8% | Skr7.31 Million | Skr9.77 Million | Skr9.18 Million | Skr1.87 Million | — |